Neoadjuvant/ Adjuvant trial of Darovasertib in Ocular Melanoma (NADOM)

  • Shackleton, Mark (Primary Chief Investigator (PCI))
  • Uhe, Micheleine (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date3/06/22 → 2/06/25

Keywords

  • Clinical Trials
  • NADOM